Cong Liang
- Topics
- Endometrial and Cervical Cancer Treatments (9 papers)RNA modifications and cancer (5 papers)Cervical Cancer and HPV Research (4 papers)
- Journals
- Nature CommunicationsSHILAP Revista de lepidopterologíaGastroenterology
- Partner nations
- ChinaHong KongUnited States
In The Last Decade
Cong Liang
25 papers receiving 860 citations
Hit Papers
Peers
Comparison fields: 5 of 92
- Molecular Biology 598
- Cancer Research 221
- Oncology 176
- Immunology 97
- Epidemiology 70
Countries citing papers authored by Cong Liang
This map shows the geographic impact of Cong Liang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Cong Liang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Cong Liang more than expected).
Fields of papers citing papers by Cong Liang
This network shows the impact of papers produced by Cong Liang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Cong Liang. The network helps show where Cong Liang may publish in the future.
Co-authorship network of co-authors of Cong Liang
This figure shows the co-authorship network connecting the top 25 collaborators of Cong Liang. A scholar is included among the top collaborators of Cong Liang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Cong Liang. Cong Liang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 0 | |
| 3 | 2 | |
| 4 | 0 | |
| 5 | 7 | |
| 6 | 1 | |
| 7 | 0 | |
| 8 | Targeting m 6 A reader YTHDF1 augments antitumour immunity and boosts anti-PD-1 efficacy in colorectal cancerbreakdown → | 154 |
| 9 | 2 | |
| 10 | 3 | |
| 11 | 91 | |
| 12 | METTL3 Inhibits Antitumor Immunity by Targeting m6A-BHLHE41-CXCL1/CXCR2 Axis to Promote Colorectal Cancerbreakdown → | 181 |
| 13 | 13 | |
| 14 | Lactobacillus gallinarum modulates the gut microbiota and produces anti-cancer metabolites to protect against colorectal tumourigenesisbreakdown → | 190 |
| 15 | 4 | |
| 16 | 11 | |
| 17 | 22 | |
| 18 | 39 | |
| 19 | 19 | |
| 20 | 34 |
About Cong Liang
Cong Liang is a scholar working on Obstetrics and Gynecology, Reproductive Medicine and Cancer Research, having authored 29 papers that have together received 864 indexed citations. Recurring topics across this work include Endometrial and Cervical Cancer Treatments (9 papers), RNA modifications and cancer (5 papers) and Cervical Cancer and HPV Research (4 papers). The work is most often cited by research in Cancer Research (221 citations), Molecular Biology (598 citations) and Obstetrics and Gynecology (59 citations). Cong Liang has collaborated with scholars based in China, Hong Kong and United States. Frequent co-authors include Jun Yu, Weixin Liu, Jianning Zhai, Yasi Pan, Huarong Chen, Dan Huang, William Ka Kei Wu, Hongyan Gou, Wei Kang and Yanqiang Ding. Their work appears in journals such as Nature Communications, SHILAP Revista de lepidopterología and Gastroenterology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.